Silo Pharma Inc. (SILO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Silo Pharma Inc.

    NASDAQ: SILO · Real-Time Price · USD
    0.60
    -0.01 (-1.72%)
    At close: Sep 08, 2025, 3:59 PM
    0.59
    -1.55%
    After-hours: Sep 08, 2025, 06:05 PM EDT

    Silo Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 72.1K 72.1K 72.1K 71.26K
    Cost of Revenue
    		 5.84K 5.84K 5.84K 5K
    Gross Profit
    		 66.26K 66.26K 66.26K 66.26K
    Operating Income
    		 -4.71M -3.86M -3.63M -2.74M
    Interest Income
    		 333.17K 398.53K 72.64K 1.21K
    Pretax Income
    		 -4.39M -3.63M -3.91M 4.18M
    Net Income
    		 -4.39M -3.7M -3.91M 3.9M
    Selling & General & Admin
    		 2.4M 3.08M 2.43M 2.27M
    Research & Development
    		 2.37M 845.09K 1.29M 693.91K
    Other Expenses
    		 -5.84K -5.84K -20K -148.5K
    Operating Expenses
    		 4.77M 3.92M 3.69M 2.81M
    Interest Expense
    		 5.08K 4.87K 2.2K 3.04K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 4.77M 3.93M 3.7M 2.82M
    Income Tax Expense
    		 n/a n/a n/a 24.88K
    Shares Outstanding (Basic)
    		 3.68M 3.08M 2.28M 1.9M
    Shares Outstanding (Diluted)
    		 3.68M 3.08M 2.28M 1.92M
    EPS (Basic)
    		 -1.19 -1.2 -1.71 1.32
    EPS (Diluted)
    		 -1.19 -1.2 -1.71 1.30
    EBITDA
    		 -4.38M -3.63M -3.91M 4.19M
    EBIT
    		 -4.39M -3.63M -3.91M 4.19M
    Depreciation & Amortization
    		 6.18K n/a n/a n/a

    Add to Watchlist